Press Releases about Illumina Inc
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina3.9.22A.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina3.16.22A.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina3.15.22B.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illuminatrivitron3.15.22A.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina_3.8.22A.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina3.3.22A.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina3.4.22A_0.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina2.28.22B.png)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina2.17.22A.png)
“The World Expands”: Celebrating Rare Disease Day in Japan
February 24, 2022
Via 3BL Media
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina2.14.22A.png)
From Patents to Patients: Meet the Women Making a Difference at Illumina
February 15, 2022
Via 3BL Media
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina2.9.22A.jpg)
Illumina to Support Neuro Genomics Project at McGill University
February 14, 2022
Via 3BL Media
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina2.2.22A.jpeg)
Illuminating Rare Disease: Get to Know SLC6A1 Connect
February 08, 2022
Via 3BL Media
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina2.3.22C.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina1.25.22A.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina2.3.22A.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina1.27.22A.png)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/906766/thumbnail-906766_0001.png)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina1.11.22C_0.jpeg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina1.14.22A.png)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illuminaboehringer1.12.22B.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/illumina1.12.22A.jpeg)
Promising Developments in Breast Cancer Treatments Ahead in 2022
January 12, 2022
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina_agendia1.12.22A.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Illumina1.11.22B.jpeg)
![](https://mms.businesswire.com/media/20220110005960/en/839588/4/Agendia_Logo.jpg)
From Agendia, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220110005288/en/629845/5/Grail_Logo_Velvet_%281%29.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.